Tectonic Therapeutic, Inc.
0.00%
0
1681087
Mar 3, 2025
Apr 7, 2025, 04:20 PM
Reporting Persons (3)
This is a joint filing. The reported shares may overlap between reporting persons and should not be summed.
| Name | Type | % of Class | Aggregate | Sole Voting | Shared Voting |
|---|---|---|---|---|---|
| Vida Ventures II, LLC | Other | 0.00% | 0 | 0 | 0 |
| Vida Ventures II-A, LLC | Other | 0.00% | 0 | 0 | 0 |
| VV Manager II, LLC | Other | 0.00% | 0 | 0 | 0 |
Disclosure Items (6)
Common Stock, $0.0001 par value per share
Tectonic Therapeutic, Inc.
490 Arsenal Way, Suite 210, Watertown, MA, 02472
The information set forth in Item 2(a) of the Original Schedule 13D is incorporated herein by reference.
The information set forth in Item 2(b) of the Original Schedule 13D is incorporated herein by reference.
The information set forth in Item 2(c) of the Original Schedule 13D is incorporated herein by reference.
The information set forth in Item 2(e) of the Original Schedule 13D is incorporated herein by reference.
The information set forth in Item 2(f) of the Original Schedule 13D is incorporated herein by reference.
The information set forth in Item 3 of the Original Schedule 13D is incorporated herein by reference.
See Items 7-11 of the cover pages of this Amendment No. 2. The information reported on such cover pages is reported as of March 4, 2025.
See Items 7-11 of the cover pages of this Amendment No. 2. The information reported on such cover pages is reported as of March 4, 2025.
On February 14, 2025, Vida II effected a pro rata distribution of 934,949 shares of Common Stock to its members without additional consideration. On February 14, 2025, Vida II-A effected a pro rata distribution of 25,944 shares of Common Stock to its members without additional consideration. On February 18, 2025, Vida II sold 7,881 shares of Common Stock at a weighted average price per share of $33.2498 for aggregate proceeds of approximately $261,577.63.On February 18, 2025, Vida II-A sold 219 shares of Common Stock at a weighted average price per share of $33.2498 for aggregate proceeds of approximately $7,258.52. On February 28, 2025, Vida II sold 20,345 shares of Common Stock at a weighted average price per share of $25.6818 for aggregate proceeds of approximately $521,419.67. On February 28, 2025, Vida II-A sold 565 shares of Common Stock at a weighted average price per share of $25.6818 for aggregate proceeds of approximately $14,468.89. On March 3, 2025, Vida II sold 584 shares of Common Stock at a weighted average price per share of $24.9606 for aggregate proceeds of approximately $14,468.79. On March 3, 2025, Vida II-A sold 16 shares of Common Stock at a weighted average price per share of $24.9606 for aggregate proceeds of approximately $401.49. On March 4, 2025, Vida II sold 37,140 shares of Common Stock at a weighted average price per share of $23.0841 for aggregate proceeds of approximately $855,438.36. On March 4, 2025, Vida II-A sold 1,031 shares of Common Stock at a weighted average price per share of $23.0841 for aggregate proceeds of approximately $23,737.58.
The information set forth in Item 5(d) of the Original Schedule 13D is incorporated herein by reference.
March 4, 2025
The information set forth in Item 6 of the Original Schedule 13D is incorporated herein by reference.